c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Seres Therapeutics (MCRB) Reports Promising Phase 1b SER-155 Trial Results in Nature Medicine
GuruFocus | Nov 3, 2026 9:52 AM EST
Related Stocks: MCRB ,
Read original article